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INVESTIGATION OF CYCLIC LIGANDS INHIBITING CD2-CD58
INTERACTIONS USING MOLECULAR DYNAMICS AND
MOLECULAR DOCKING APPROACHES
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The CD2-CD58 protein-protein interaction is known to favor the recognition of antigen presenting cells by T
cells. Molecular Dynamics (MD) and molecular docking calculations are carried out to study the structural,
energetics, and dynamical properties of three known cyclic CD58 ligands, named P6 [1-3], P7 [1,4], and RTD-c
[3]. Each ligand, connected via turn inducers, mimics the C and F β-strands of protein CD2. The MD analyses
focus on the location of the ligands on the surface of CD58 and on the direct and water-mediated hydrogen
bonds (Hbonds) they form with that receptor. Ligand P6, with a sequence close to the experimental β-strands of
CD2, presents characteristics that explain its higher experimental affinity, e.g., the lower mobility and flexibility
at the CD58 surface, and the larger number and occurrence frequency of ligand-CD58 Hbonds. For the two other
ligands, the structural modifications lead to changes in the binding pattern with CD58 and its dynamics. In
parallel, a large set of molecular docking calculations, carried out with various search spaces and docking
algorithms, are compared to provide a consensus view of the preferred ligand binding modes. The analysis of the
ligand side chain locations yields results that are consistent with the CD2-CD58 crystal structure and suggest
various binding modes of the experimentally identified hot spot of the ligands, i.e., Tyr86. P6 is shown to form a
number of contacts that are also present in the experimental CD2-CD58 structure.
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